Gujarat Kidney and Super Speciality Share Price Today | Stock Price & Gujarat Kidney and Super Speciality Share Screener
As of October 5, 2026, the live Gujarat Kidney and Super Speciality share price (NSE: GKSL) is ₹190.34 on NSE and ₹189.90 on BSE, down 2.02% from the previous close, with shares trading between ₹183.02 and ₹199.00 in today's trading session, and a 52-week range of ₹99.36–₹194.27. Check GKSL 52-week performance for the annual price range and momentum. Use the Gujarat Kidney and Super Speciality stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Gujarat Kidney and Super Speciality opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹31 and net income of ₹5, with EBITDA of ₹7, an operating margin of 21.0% and a profit margin of 16.1%.
Gujarat Kidney and Super Speciality Share Price Chart
Track the current stock price of Gujarat Kidney and Super Speciality with an interactive chart. Analyse GKSL share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Gujarat Kidney and Super Speciality stock quote in one place.
The quote of ₹190.34 sits between the 52-week low of ₹99.36 and the 52-week high of ₹194.27, and the latest session moved -2.02% from the previous close.
Gujarat Kidney and Super Speciality Company Profile - Fundamental Screener
Screen Gujarat Kidney and Super Speciality company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for GKSL shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare Services sector and the Hospitals industry, and it trades under ISIN INE0V0W01025.
Company Details
Classification
Identifiers and Leadership
Gujarat Kidney and Super Speciality Balance Sheet Screener
Screen GKSL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹298, up from ₹55 in 2025.
Latest statistics put total assets at ₹298 and shareholder funds at ₹255, with a leverage ratio of 0.13.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
Assets |
|||||
| Total Assets | 298 | 55 | 21 | 4 | 4 |
| Current Assets | 105 | 22 | 7 | 1 | 1 |
| Fixed Assets | 129 | 31 | 14 | 0 | 3 |
Liabilities |
|||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 15 | 7 | 6 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
|||||
| Total Equity | 255 | 27 | 11 | 0 | 0 |
| Share Capital | 16 | 11 | 0 | 0 | 0 |
| Reserves & Surplus | 237 | 15 | 2 | 0 | 0 |
Gujarat Kidney and Super Speciality Income Statement Screener - Profit & Revenue Analysis
Screen Gujarat Kidney and Super Speciality income statement and profit fundamentals. Analyze GKSL quarterly results. Gujarat Kidney and Super Speciality reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Mar, revenue was ₹31 and net profit was ₹5, equal to earnings per unit of ₹0.81, at an operating margin of 21%.
In that period expenses were ₹24, interest cost ₹1 and tax ₹0. The next period listed, 2026-Jun, shows revenue of ₹35 and net profit of ₹5.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | ||||||||
| Revenue | 31 | 35 | 10 | 15 | 13 | 23 | 9 | 12 |
| Expenses | 24 | 26 | 7 | 7 | 8 | 16 | 5 | 7 |
Operating Costs and Margins | ||||||||
| EBITDA | 7 | 9 | 3 | 9 | 5 | 7 | 5 | 5 |
| Operating Profit % | 21.00% | 24.00% | 27.00% | 57.00% | 40.00% | 30.00% | 52.00% | 39.00% |
| Depreciation | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
Profit and Earnings | ||||||||
| Profit Before Tax | 5 | 7 | 2 | 8 | 4 | 5 | 4 | 4 |
| Tax | 0 | 2 | 0 | 2 | 1 | 1 | 1 | 1 |
| Net Profit | 5 | 5 | 1 | 5 | 3 | 4 | 3 | 3 |
| EPS | 0.81 | 0.66 | 0.25 | 0.85 | 0.47 | 0.52 | 0.65 | 0.52 |
Gujarat Kidney and Super Speciality Cash Flow Screener - Liquidity Fundamentals
Screen GKSL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities used ₹4, and net cash flow was an inflow of ₹11.
Over the same period, investing activities used ₹214 and financing activities provided ₹228.
| Item | 2026-March | 2025-March | 2024-March | 2023-March |
|---|---|---|---|---|
Cash from Operations and Investing | ||||
| Operating Activities | -4 | 14 | 1 | 0 |
| Investing Activities | -214 | -18 | 0 | 0 |
Financing and Net Cash | ||||
| Financing Activities | 228 | 6 | -1 | 0 |
| Net Cash Flow | 11 | 2 | 1 | 0 |
Gujarat Kidney and Super Speciality Shareholding Pattern Screener
See Gujarat Kidney and Super Speciality shareholding pattern with promoter, FII, and DII holdings. Check Gujarat Kidney and Super Speciality promoter holding and ownership changes for GKSL on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 71.45%, foreign institutions 4.88%, domestic institutions 0.56% and the public 10.64%, spread across 18,301 shareholders.
The shareholder count was 18,301 in 2026-Mar, compared with 18,301 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Dec |
|---|---|---|---|---|
Promoter Holding | ||||
| Promoter Holding | 71.45% | 71.45% | 99.10% | 71.45% |
Institutional Investors | ||||
| FII Holding | 4.88% | 4.88% | 0.00% | 10.47% |
| DII Holding | 0.56% | 0.56% | 0.00% | 1.67% |
Government, Public and Others | ||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 10.64% | 10.64% | 0.00% | 11.57% |
| Other Holding | 12.46% | 12.46% | 0.90% | 4.84% |
| Shareholder Count | 18,301 | 18,301 | 7 | 7 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Gujarat Kidney and Super Speciality. Gujarat Kidney and Super Speciality dividend yield can be compared with peers and other stocks in the market.
Gujarat Kidney and Super Speciality Stock Index Membership - Nifty & Sensex
See which indices include Gujarat Kidney and Super Speciality stock. Check GKSL index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Gujarat Kidney and Super Speciality Market Events Screener - Corporate Actions
Get Gujarat Kidney and Super Speciality corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Gujarat Kidney and Super Speciality stock events that may affect GKSL share price, along with derivatives, futures and options activity and sector gainers.
4 corporate actions are listed, the most recent entry being Annual General Meeting dated September 28, 2026, with a record date of September 28, 2026.
It is followed by Quarterly Result Announcement dated August 14, 2026 and Quarterly Result Announcement dated May 28, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-28 | 2026-09-28 | Annual General Meeting | NA | 13.39% |
| 2026-08-14 | 2026-08-14 | Quarterly Result Announcement | NA | 1.20% |
| 2026-05-28 | 2026-05-28 | Quarterly Result Announcement | NA | -4.88% |
| 2026-02-14 | 2026-02-14 | Quarterly Result Announcement | NA | 1.61% |
Gujarat Kidney and Super Speciality Competitors Screener - Peer Stocks Comparison
Screen GKSL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 118,910 | 57.61 | 25,420 | 15.58% | 2,003 | 43.13 |
| Max Healthcare Institute | 91,900 | 65.73 | 8,536 | 18.82% | 1,442 | 36.74 |
| Aster DM Quality Care | 61,562 | 176.75 | 4,769 | 11.25% | 427 | 36.84 |
| Fortis Healthcare | 59,113 | 57.76 | 9,179 | 16.93% | 1,064 | 25.57 |
| Global Health | 37,645 | 68.91 | 4,509 | 19.56% | 554 | 44.47 |
| Narayana Hrudayalaya | 36,129 | 45.13 | 7,996 | 43.43% | 811 | 38.14 |
| Krishna Institute of Medical Sciences | 31,139 | 166.33 | 3,931 | 28.16% | 242 | 45.36 |
| Dr. Agarwal's Health Care | 15,461 | 84.73 | 2,125 | 20.92% | 168 | 44.18 |
| Rainbow Childrens Medicare | 13,510 | 47.88 | 1,747 | 11.49% | 282 | 31.72 |
| Park Medi World | 11,813 | 40.25 | 1,711 | 19.99% | 274 | 41.32 |
Gujarat Kidney and Super Speciality Company Announcements - News & Reports Screener
Screen GKSL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated .
The next most recent announcements are dated October 4, 2026 and October 2, 2026.
| Date | Update | Actions |
|---|---|---|
| Shareholder Meeting / Postal Ballot-Scrutinizers Report | - | |
| 2026-10-04 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-10-02 | Closure of Trading Window | - |
| 2026-09-25 | Reg. 34 (1) Annual Report. | - |
| 2026-09-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-03 | AGM To Be Held On 28-09-2026 | - |
| 2026-09-03 | Reg. 34 (1) Annual Report. | - |
| 2026-09-03 | Reg. 34 (1) Annual Report. | - |
| 2026-09-01 | Intimation Of Pre-Advertisement-Notice Of Annual General Meeting Of The Company | - |
| 2026-08-27 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-24 | Outcome Of Board Meeting | - |
| 2026-08-24 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-08-24 | Board Meeting Outcome for Outcome Of Board Meeting Held On 24-08-2026 | - |
| 2026-08-24 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | - |
| 2026-08-24 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-08-14 | Statement Of Deviation & Variation As On June 30 2026 | - |
| 2026-08-14 | Financial Results For Quarter Ended June 2026 | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-08-14 | Board Meeting Outcome for Outcome Of Board Meeting | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹190.34, within a 52-week range of ₹99.36 to ₹194.27. The P/E ratio is 83.47 and the P/B ratio is 5.53, with earnings per unit of ₹2.49. Market capitalisation stands at ₹1,434.47 Cr. The company operates in the Healthcare Services sector, in the Hospitals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 5, 2026. This page covers 5 balance sheet periods, 8 income statement periods, 4 cash flow years and 4 shareholding periods. Information is provided for research and is not investment advice.